Pfizer reports phase 2 data for 25-valent pneumococcal vaccine
AI Summary
Pfizer reported Phase 2 results for a 25-valent pneumococcal vaccine. The article provides no further details on the results or development plans.
Related Articles
Maternal deaths drop 60% in FG intervention areas — Minister
Punch Nigeria —
What are biomarkers? How doctors assess health and pooling people's cells reveals new markers—a biologist explains
Medical Xpress —
Women may face higher PTSD risk, and biomarker could help predict it
Medical Xpress —
Dolphins' Zach Sieler (biceps) out for season: report
Yahoo Sports —
Produtor perde mais de 1,7 mil litros de leite após falta de energia na zona rural de Cambuci
Globo —
Ich bin Herzchirurgin. Diese untypischen Symptome werden oft falsch eingeordnet
Die Welt —